Results of using the neuroprotective drug Cellex in non-traumatic intracranial hemorrhage
Introduction. In the Russian Federation, neuroprotective agents are widely used in the treatment of patients with ischemic stroke. There are accumulated data on the efficacy and safety of the neuroprotective agent Cellex® in ischemic stroke. The use of this drug in hemorrhagic stroke has been studie...
Asıl Yazarlar: | Kh. D. Mongush, A. V. Kyrgys, A. A. Sedip, A. E. Shyyrap, A. B. Ondar, M. G. Zhestikova |
---|---|
Materyal Türü: | Makale |
Dil: | Russian |
Baskı/Yayın Bilgisi: |
Remedium Group LLC
2022-03-01
|
Seri Bilgileri: | Медицинский совет |
Konular: | |
Online Erişim: | https://www.med-sovet.pro/jour/article/view/6755 |
Benzer Materyaller
-
Efficacy of Cellex in patients with mild cognitive impairment
Yazar:: B. A. Abusueva, ve diğerleri
Baskı/Yayın Bilgisi: (2019-04-01) -
NEUROPROTECTION INFLUENCE ON COURSE OF CEREBRAL STROKE
Yazar:: G. N. BELSKAYA, ve diğerleri
Baskı/Yayın Bilgisi: (2016-12-01) -
Neuroprotection by Ozanimod Following Intracerebral Hemorrhage in Mice
Yazar:: Fei Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01) -
Drug-induced non-traumatic intracranial hemorrhage associated with the use of anticoagulants and antiplatelet agents
Yazar:: O. D. Ostroumova, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01) -
Acute albumin administration as therapy for intracerebral hemorrhage: A literature review
Yazar:: Yirong Cao, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)